ReviewDermatology practical & conceptual2026
Focal Dermal Hypoplasia in Males: A Systematic Review.
Review in Dermatology practical & conceptual, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFocal dermal hypoplasia (FDH) is an X-linked dominant disorder characterized by dermal atrophy, fat herniations, telangiectasias, and pigmentary changes along Blaschko's lines, with multisystem involvement affecting the teeth, nails, eyes, and the skeletal, cardiovascular, and other systems. Initially thought embryonically lethal in males, later reports identified somatic mosaicism as a survival mechanism. The male phenotype remains incompletely defined.
objectivesTo systematically review reported male FDH cases to consolidate phenotypic patterns, identify key features, and explore genotype-phenotype correlations.
methodsA systematic review of PubMed was conducted with no restrictions on publication date. This review was conducted in accordance with the PRISMA guidelines. Inclusion criteria were case reports and systematic reviews solely investigating FDH or Goltz syndrome.
resultsForty-five patient cases were identified across 38 case reports and studies. Dermal and skeletal involvement primarily involved extremities. Ophthalmological and dental anomalies, including microphthalmia, colobomas, and enamel defects, were variably present. PORCN variants were confirmed in all but one genetically tested patient, though phenotypes varied. The retrospective nature likely biased toward more severe or unusual presentations.
conclusionsFDH in males exhibits marked clinical variability. The observed heterogeneity in histopathological findings reinforces the need for flexible diagnostic criteria, with genetic testing for PORCN variants recommended when clinical suspicion remains high. A multidisciplinary approach is recommended, with surveillance of ocular, dental, and skeletal manifestations even in patients with minimal cutaneous findings. Further research into PORCN function and Wnt signaling is needed to refine genotype-phenotype relationships and explore alternative disease mechanisms.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.